Mologic has joined forces with Fraunhofer Centre for Applied Photonics (CAP), an organization that specializes in applied laser research and development, to develop a rapid point-of-care (POC) test to diagnose in a primary care setting bacterial urinary tract infections and any associated antibiotic susceptibility. The project aims to help reduce the incidence of antimicrobial resistance. The two U.K.-based organizations have received a £900,000 development grant from Small Business Research Initiative Healthcare, a National Health Service England initiative that supports innovative companies striving to solve healthcare problems. Mologic and Fraunhofer CAP’s POC test will combine nanophotonic waveguides and microfluidics to measure how bacteria respond to minute quantities of antibiotics. The project will leverage Fraunhofer CAP’s photonic technology in combination with Mologic’s experience commercializing in vitro diagnostics. Other partners in the initiative include the product design firm Wideblue, Kelvin Nanotechnology, the University of Strathclyde, and Barclay Medical Practice, all based in Glasgow, U.K.